Laurence Slama

1.0k total citations · 1 hit paper
23 papers, 462 citations indexed

About

Laurence Slama is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Laurence Slama has authored 23 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Virology, 11 papers in Infectious Diseases and 11 papers in Epidemiology. Recurrent topics in Laurence Slama's work include HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (8 papers). Laurence Slama is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS Research and Interventions (8 papers) and HIV/AIDS drug development and treatment (8 papers). Laurence Slama collaborates with scholars based in France, United States and Puerto Rico. Laurence Slama's co-authors include Gilles Pialoux, Lisa A. Chakrabarti, Jean‐François Delfraissy, Jacques Thèze, Olivier Lambotte, Marguerite Guiguet, Pierre de Truchis, Stéphanie Dominguez, Marc‐Antoine Valantin and Assia Samri and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Virology and Journal of Hepatology.

In The Last Decade

Laurence Slama

22 papers receiving 456 citations

Hit Papers

Doxycycline prophylaxis and meningococcal group B vaccine... 2024 2026 2024 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design
    2024 69 citations Jean‐Michel Molina, Béatrice Berçot et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurence Slama France 13 211 188 176 106 104 23 462
Renato Maserati Italy 14 263 1.2× 139 0.7× 236 1.3× 81 0.8× 77 0.7× 24 452
Kailapuri G. Murugavel India 16 232 1.1× 340 1.8× 149 0.8× 75 0.7× 172 1.7× 47 599
Roberta Halpenny Canada 11 260 1.2× 199 1.1× 349 2.0× 196 1.8× 54 0.5× 18 624
Manjeetha Jaggernath United States 11 178 0.8× 133 0.7× 103 0.6× 74 0.7× 56 0.5× 17 369
M. Prins Netherlands 9 255 1.2× 219 1.2× 171 1.0× 30 0.3× 72 0.7× 24 431
Tesfaye Tilahun Ethiopia 8 197 0.9× 138 0.7× 152 0.9× 75 0.7× 43 0.4× 12 384
M Vandenbruaene Belgium 11 163 0.8× 241 1.3× 254 1.4× 274 2.6× 69 0.7× 20 646
Paolo Costigliola Italy 15 332 1.6× 255 1.4× 156 0.9× 50 0.5× 32 0.3× 34 573
Caroline E. Mullis United States 14 402 1.9× 222 1.2× 362 2.1× 36 0.3× 60 0.6× 26 564
Stacey Chapman United States 9 147 0.7× 176 0.9× 98 0.6× 23 0.2× 146 1.4× 14 329

Countries citing papers authored by Laurence Slama

Since Specialization
Citations

This map shows the geographic impact of Laurence Slama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurence Slama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurence Slama more than expected).

Fields of papers citing papers by Laurence Slama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurence Slama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurence Slama. The network helps show where Laurence Slama may publish in the future.

Co-authorship network of co-authors of Laurence Slama

This figure shows the co-authorship network connecting the top 25 collaborators of Laurence Slama. A scholar is included among the top collaborators of Laurence Slama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurence Slama. Laurence Slama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Molina, Jean‐Michel, Béatrice Berçot, Lambert Assoumou, et al.. (2024). Doxycycline prophylaxis and meningococcal group B vaccine to prevent bacterial sexually transmitted infections in France (ANRS 174 DOXYVAC): a multicentre, open-label, randomised trial with a 2 × 2 factorial design. The Lancet Infectious Diseases. 24(10). 1093–1104. 69 indexed citations breakdown →
2.
Molina, Jean‐Michel, Jade Ghosn, Constance Delaugerre, et al.. (2021). Incidence of HIV infection with daily or on-demand oral prep with TDF/FTC in france. 29(1). 43–44. 8 indexed citations
3.
Raffi, François, Chloe Orkin, Amanda Clarke, et al.. (2017). Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. 75(2). 226–231. 60 indexed citations
4.
Lebrette, Marie-Gisèle, et al.. (2016). Bacterial chondritis complications following ear piercing. Médecine et Maladies Infectieuses. 47(1). 26–31. 4 indexed citations
5.
6.
Slama, Laurence, Xiuhong Li, Todd T. Brown, et al.. (2013). Increases in Duration of First Highly Active Antiretroviral Therapy Over Time (1996–2009) and Associated Factors in the Multicenter AIDS Cohort Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 65(1). 57–64. 21 indexed citations
7.
Bado, Guillaume, Pauline Penot, Corinne Amiel, et al.. (2013). Hepatitis B seroprevalence in HIV-infected patients consulting in a public day care unit in Bobo Dioulasso, Burkina Faso. Médecine et Maladies Infectieuses. 43(5). 202–207. 12 indexed citations
8.
Guiguet, Marguerite, Marc‐Antoine Valantin, Assia Samri, et al.. (2012). Lack of TGF-β production by hepatitis C virus-specific T cells during HCV acute phase is associated with HCV clearance in HIV coinfection. Journal of Hepatology. 56(6). 1259–1268. 9 indexed citations
9.
Ghosn, Jade, Laurence Slama, Luminita Schneider, et al.. (2012). Switching to darunavir/ritonavir 800/100 mg once‐daily containing regimen maintains virological control in fully suppressed pre‐treated patients infected with HIV‐1. Journal of Medical Virology. 85(1). 8–15. 12 indexed citations
10.
Landires, Iván, Olivier Lambotte, Pierre de Truchis, et al.. (2011). HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization. AIDS. 25(15). 1843–1853. 28 indexed citations
11.
Géri, Guillaume, M. Travis Maynard, Éric Rosenthal, et al.. (2011). Épidémiologie et prise en charge des patients mono-infectés par le virus de l’hépatite C en 2010 (EPIC 2010), et comparaison aux enquêtes 1995 et 2001. La Revue de Médecine Interne. 32. S94–S95. 1 indexed citations
12.
Chakvetadze, Catherine, Firouzé Bani‐Sadr, Catherine Le Pendeven, et al.. (2010). Serologic Response to Hepatitis B Vaccination in HIV‐Infected Patients with Isolated Positivity for Antibodies to Hepatitis B Core Antigen. Clinical Infectious Diseases. 50(8). 1184–1186. 25 indexed citations
13.
Lescure, François‐Xavier, Jean‐Marie Poirier, Jean‐Luc Meynard, et al.. (2010). Factors predictive of virological failure on atazanavir in 310 HIV-infected patients. AIDS. 24(10). 1593–1595. 5 indexed citations
14.
Morand‐Joubert, Laurence, Karine Lacombe, J.‐M. POIRIER, et al.. (2009). Impact of reduced dosing of lopinavir/ritonavir in virologically controlled HIV-infected patients: the Kaledose trial. Journal of Antimicrobial Chemotherapy. 65(1). 125–128. 3 indexed citations
15.
Schnuriger, Aurélie, Stéphanie Dominguez, Marguerite Guiguet, et al.. (2009). Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus. AIDS. 23(16). 2079–2089. 52 indexed citations
16.
Silbermann, Benjamin, Michel Tod, Corinne Desaint, et al.. (2008). Short Communication: Long-Term Persistence of Vaccine-Induced HIV Seropositivity among Healthy Volunteers. AIDS Research and Human Retroviruses. 24(11). 1445–1448. 18 indexed citations
17.
Aït-Mohand, Hocine, Manuela Bonmarchand, Marguerite Guiguet, et al.. (2008). Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study. HIV Medicine. 9(9). 738–746. 13 indexed citations
18.
Pialoux, Gilles, Hakim Hocini, Dominique Salmon‐Céron, et al.. (2007). Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: The ANRS VAC14 study. Vaccine. 26(21). 2657–2666. 29 indexed citations
19.
Pialoux, Gilles & Laurence Slama. (2005). Vaccins préventifs anti-VIH. La Presse Médicale. 34(20). 1592–1596. 1 indexed citations
20.
Guiard–Schmid, Jean–Baptiste, Laurence Slama, Caroline Maslo, et al.. (2003). Le piercing et ses complications infectieuses : Un enjeu de santé publique en France. The Sciences. 42–51.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renato Maserati Breakdown of academic impact, for papers by Kailapuri G. Murugavel Breakdown of academic impact, for papers by Roberta Halpenny Breakdown of academic impact, for papers by Manjeetha Jaggernath Breakdown of academic impact, for papers by M. Prins Breakdown of academic impact, for papers by Tesfaye Tilahun Breakdown of academic impact, for papers by M Vandenbruaene Breakdown of academic impact, for papers by Paolo Costigliola Breakdown of academic impact, for papers by Caroline E. Mullis Breakdown of academic impact, for papers by Stacey Chapman
Rankless by CCL
2026